Search results for "Piperidine"

showing 10 items of 236 documents

Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies

2017

Ibrutinib is highly active in treating mantle cell lymphoma (MCL), an aggressive B-cell lymphoma. We pooled data from three ibrutinib studies to explore the impact of baseline patient characteristics on treatment response. Patients with relapsed/refractory MCL (n = 370) treated with ibrutinib had an objective response rate (ORR) of 66% (20% complete response; 46% partial response); median duration of response (DOR), progression-free survival (PFS) and overall survival (OS) were 18.6, 12.8 and 25.0 months, respectively. Univariate analyses showed patients with one versus >one prior line of therapy had longer OS. Multivariate analyses identified that one prior line of therapy affected PFS; Ea…

Oncologymedicine.medical_specialtyECOG Performance StatusAntineoplastic AgentsLymphoma Mantle-CellBlastoidArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternational Prognostic IndexPiperidinesRecurrenceInternal medicinemedicineHumansneoplasmsSurvival analysisUnivariate analysisPerformance statusbiologybusiness.industryAdenineHematologybiology.organism_classificationmedicine.diseaseSurvival AnalysisSurgeryPyrimidinesTreatment Outcomechemistry030220 oncology & carcinogenesisIbrutinibPyrazolesMantle cell lymphomabusiness030215 immunologyBritish Journal of Haematology
researchProduct

Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis

2019

Oncologymedicine.medical_specialtySalvage therapyDrug resistanceLymphoma Mantle-Cellchemistry.chemical_compoundText miningPiperidinesInternal medicinemedicineHumansOnline Only ArticlesSurvival rateSalvage TherapyClinical Trials as Topicbusiness.industryAdenineHematologymedicine.diseasePrognosisLymphomaSurvival RatePyrimidineschemistryDrug Resistance NeoplasmIbrutinibRelapsed refractoryPyrazolesMantle cell lymphomaNeoplasm Recurrence LocalbusinessFollow-Up Studies
researchProduct

Effects of brofaremine (CGP 11 305A), a short-acting, reversible, and selective inhibitor of MAO-A on sleep, nocturnal penile tumescence and nocturna…

1987

The effects of brofaremine (CGP 11 305A), a short-acting, reversible and selective inhibitor of MAO-A, on sleep, nocturnal penile tumescence (NPT) and hormonal secretion during the night were studied during a long-term trial. Three healthy males underwent sleep-EEG and NPT recordings during consecutive nights (1) under placebo, (2) under stepwise increasing dosages of brofaremine and (3) under placebo after withdrawal. Hormone profiles were sampled during selected nights to analyze the plasma concentration of cortisol, HGH, prolactin, testosterone, LH and FSH. REM sleep was suppressed markedly under 150 mg brofaremine, while stages 1 and 2 increased. In comparison to the effect of irreversi…

PharmacologyAdultMalemedicine.medical_specialtyMonoamine Oxidase Inhibitorsbusiness.industryPenile ErectionSleep REMElectroencephalographyNocturnalPlaceboSleep in non-human animalsREM reboundProlactinHormonesEndocrinologyPiperidinesInternal medicineNocturnal penile tumescencemedicineHumansbusinessSleepTestosteroneHormonePsychopharmacology
researchProduct

X-ray Crystal Structure and Hirshfeld Analysis of Gem-Aminals-Based Morpholine, Pyrrolidine, and Piperidine Moieties

2020

The gem-aminals of 1,2-dimorpholinoethane (1) and 1-morpholino-3-morpholinium bromide propane (2) were synthesized by reaction of two molar ratio of morpholine with the halogenating agents in the presence of basic condition (K2CO3) in acetone at room temperature (RT) overnight. The structures of the centro-symmetric compound 1 and the morpholinium salt derivative 2 were assigned unambiguous by single crystal X-ray diffraction analysis and compared with the 1,2-di(pyrrolidin-1-yl)ethane 3 and 1,2-di(piperidin-1-yl)ethane 4. The 1,2-dimorpholinoethane molecule has a center of symmetry at the midpoint of the C-C bond of the ethyl moiety leading to two equivalent halves. It crystallized in mono…

Physics and Astronomy (miscellaneous)General MathematicspyrrolidineaminalsCrystal structure010402 general chemistryDFT01 natural sciencesPyrrolidineX-raychemistry.chemical_compoundMorpholinemorpholineComputer Science (miscellaneous)MoleculeHOMO/LUMOorgaaniset yhdisteetamiinit010405 organic chemistrylcsh:MathematicstiheysfunktionaaliteoriaHirshfeld analysispiperidinelcsh:QA1-9390104 chemical sciencesCrystallographyMolecular geometrychemistryChemistry (miscellaneous)Single crystalröntgenkristallografiaMonoclinic crystal systemSymmetry
researchProduct

Regioselective C–H amination of free base porphyrins via electrogenerated pyridinium-porphyrins and stabilization of easily oxidized amino-porphyrins…

2020

Four free base aminoporphyrins were synthesized in two steps via regioselective anodic nucleophilic substitution with pyridine followed by ring opening of the electrogenerated pyridinium with piperidine. The X-ray crystallographic structure of the unstable 2-aminotetraphenylporphyrin was solved. Protonation of this latter compound leads to the stable diiminium porphyrin salt.

Protonation010402 general chemistry01 natural sciencesCatalysischemistry.chemical_compound[CHIM.ANAL]Chemical Sciences/Analytical chemistryPyridinePolymer chemistryMaterials ChemistryNucleophilic substitution[CHIM.COOR]Chemical Sciences/Coordination chemistryAmination[CHIM.ORGA]Chemical Sciences/Organic chemistry010405 organic chemistryMetals and AlloysFree base[CHIM.MATE]Chemical Sciences/Material chemistryGeneral ChemistryPorphyrin0104 chemical sciencesSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialschemistryCeramics and CompositesPyridiniumPiperidineChemical Communications
researchProduct

Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression

2009

Both agonists (e.g. Delta(9)-tetrahydrocannabinol, nabilone) and antagonists (e.g. rimonabant, taranabant) of the cannabinoid type-1 (CB(1)) receptor have been explored as therapeutic agents in diverse fields of medicine such as pain management and obesity with associated metabolic dysregulation, respectively. CB(1) receptors are widely distributed in the central nervous system and are involved in the modulation of emotion, stress and habituation responses, behaviours that are thought to be dysregulated in human psychiatric disorders. Accordingly, CB(1) receptor activation may, in some cases, precipitate episodes of psychosis and panic, while its inhibition may lead to behaviours reminiscen…

PsychosisCannabinoid receptorEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPharmacologyEndocrinologyTaranabantPiperidinesReceptor Cannabinoid CB1RimonabantCannabinoid Receptor ModulatorsmedicineAnimalsHumansDronabinolDepressive Disorderbusiness.industryCannabinoid Receptor Agonistsmedicine.diseaseAnxiety DisordersEndocannabinoid systemNabiloneAffectPyrazolesCannabinoidRimonabantbusinessNeurosciencemedicine.drugBest Practice & Research Clinical Endocrinology & Metabolism
researchProduct

Muscarinic M2 receptors in acetylcholine-isoproterenol functional antagonism in human isolated bronchus

2002

The muscarinic functional antagonism of isoproterenol relaxation and the contribution of muscarinic M2 receptors were examined in human isolated bronchus. In intact tissues, acetylcholine (ACh) precontraction decreased isoproterenol potency and maximal relaxation (−log EC50 shift = −1.49 ± 0.16 and Emax inhibition for 100 μM ACh = 30%) more than the same levels of histamine contraction. The M2receptor-selective antagonist methoctramine (1 μM) reduced this antagonism in ACh- but not histamine-contracted tissues. Similar results were obtained for forskolin-induced relaxation. After selective inactivation of M3 receptors with 4-diphenylacetoxy- N-(2-chloroethyl)piperadine hydrochloric acid (3…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyLung NeoplasmsPhysiologyMuscle RelaxationBronchiMuscarinic AntagonistsIn Vitro Techniqueschemistry.chemical_compoundPiperidinesPhysiology (medical)Internal medicineIsoprenalineMuscarinic acetylcholine receptorCyclic AMPmedicineMethoctramineHumansNeurotransmitterAcetylcholine receptorReceptor Muscarinic M2BronchusColforsinIsoproterenolMuscle SmoothMuscarinic acetylcholine receptor M2Cell BiologyReceptors MuscarinicAcetylcholinemedicine.anatomical_structureEndocrinologychemistryAcetylcholineMuscle Contractionmedicine.drugAmerican Journal of Physiology-Lung Cellular and Molecular Physiology
researchProduct

Dragon method for finding novel tyrosinase inhibitors: Biosilico identification and experimental in vitro assays

2006

QSAR (quantitative structure-activity relationship) studies of tyrosinase inhibitors employing Dragon descriptors and linear discriminant analysis (LDA) are presented here. A data set of 653 compounds, 245 with tyrosinase inhibitory activity and 408 having other clinical uses were used. The active data set was processed by k-means cluster analysis in order to design training and prediction series. Seven LDA-based QSAR models were obtained. The discriminant functions applied showed a globally good classification of 99.79% for the best model Class=-96.067+1.988 x 10(2)X0Av +9 1.907 BIC3 + 6.853 CIC1 in the training set. External validation processes to assess the robustness and predictive pow…

Quantitative structure–activity relationshipDatabases FactualStereochemistryTyrosinaseQuantitative Structure-Activity RelationshipComputational biologyLigandsChemometricschemistry.chemical_compoundPiperidinesDrug DiscoveryComputer SimulationPharmacologyVirtual screeningbiologyChemistryOrganic ChemistryIn vitro toxicologyComputational BiologyDiscriminant AnalysisReproducibility of ResultsGeneral MedicineLinear discriminant analysisEnzyme inhibitorDrug Designbiology.proteinPeptidesKojic acidSoftwareEuropean Journal of Medicinal Chemistry
researchProduct

CCDC 943697: Experimental Crystal Structure Determination

2018

Related Article: P.S. Grace, J.S. Nirmalram, B.R.D. Nayagam, D. Schollmeyer|2018|IUCrData|3|x181237|doi:10.1107/S2414314618012373

Space GroupCrystallography11'-[(2356-tetramethyl-14-phenylene)bis(methylene)]dipiperidineCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1969082: Experimental Crystal Structure Determination

2020

Related Article: Md. Mahbubur Rahman, Chengwei Liu, Elwira Bisz, Błażej Dziuk, Roger Lalancette, Qi Wang, Hao Chen, Roman Szostak, Michal Szostak|2020|J.Org.Chem.|85|5475|doi:10.1021/acs.joc.0c00227

Space GroupCrystallography1-benzoyl-44-dimethylpiperidine-26-dioneCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct